4//SEC Filing
ARGOS THERAPEUTICS INC 4
Accession 0000904454-16-001459
CIK 0001105533operating
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:20 PM ET
Size
9.2 KB
Accession
0000904454-16-001459
Insider Transaction Report
Form 4
Pharmstandard International S.A.
10% Owner
Transactions
- Purchase
Common Stock
2016-09-29$4.60/sh+15,100$69,460→ 13,169,335 total(indirect: See footnote) - Purchase
Common Stock
2016-09-28$4.54/sh+28,518$129,472→ 13,154,235 total(indirect: See footnote)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company Pharmstandard. As the parent entity, Public Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.58 to $4.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001105533
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:20 PM ET
- Size
- 9.2 KB